Severe acute respiratory syndrome coronavirus (SARS‐CoV)‐2, a novel coronavirus from
the same family as SARS‐CoV and Middle East respiratory syndrome coronavirus, has …

Background Since being first reported in Wuhan, China, in December 8, 2019, the outbreak
of the novel coronavirus, now known as COVID-19, has spread globally. Some case studies …

An acute respiratory disease caused by a severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) that surfaced in China in late 2019, continues to spread rapidly across the …

Last decade witnessed the outbreak of many life-threatening human pathogens including
Nipah, Ebola, Chikungunya, Zika, Middle East respiratory syndrome coronavirus (MERS …

Abstract Coronavirus disease 2019 (COVID-19) emerged in Hubei Province, China in
December 2019 and has since become a global pandemic, with hundreds of thousands of …

There are significant misconceptions and many obstacles in the way of illuminating the
epidemiological and clinical aspects of COVID-19 as a new emerging epidemic. In addition …

Recent international epidemics of coronavirus-associated illnesses underscore the urgent
medical and public health need for vaccine development and regulatory body approved …

The demand for recombinant proteins in terms of quality, quantity, and diversity is increasing
steadily, which is attracting global attention for the development of new recombinant protein …

In the midst of the severe acute respiratory syndrome coronavirus 2 pandemic and its
attendant morbidity and mortality, safe and efficacious vaccines are needed that induce …

A cluster of pneumonia (COVID‐19) cases have been found in Wuhan China in late
December, 2019, and subsequently, a novel coronavirus with a positive stranded RNA was …